| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CELGENE CORP | 3,609,298 | 355,985,000 | 14.05% | ||
| 2 | INCYTE | 3,840,406 | 307,156,000 | 12.12% | ||
| 3 | GILEAD SCIENCES INC | 2,774,596 | 231,457,000 | 9.14% | ||
| 4 | IONIS PHARMACEUTICALS INC | 7,104,838 | 165,472,000 | 6.53% | ||
| 5 | RADIUS HEALTH | 4,360,399 | 160,245,000 | 6.33% | ||
| 6 | NEUROCRINE BIOSCIE COM USD0.001 | 3,121,552 | 141,875,000 | 5.60% | ||
| 7 | ALEXION PHARMACEUTIC | 1,179,428 | 137,710,000 | 5.44% | ||
| 8 | VERTEX PHARMACEUT | 1,415,445 | 121,757,000 | 4.81% | ||
| 9 | MEDIVATION INC | 1,991,112 | 120,064,000 | 4.74% | ||
| 10 | AGIOS PHARMACEUTICALS INC | 2,363,321 | 99,011,000 | 3.91% | ||
| 11 | TESARO INC | 1,154,582 | 97,043,000 | 3.83% | ||
| 12 | REGENERON PHARMACEUTICALS | 205,000 | 71,592,000 | 2.83% | ||
| 13 | ALNYLAM PHARMACEUTICALS INC | 1,191,338 | 66,107,000 | 2.61% | ||
| 14 | HALOZYME THERAPEUTICS INC | 7,379,832 | 63,688,000 | 2.51% | ||
| 15 | NOVAVAX INC COM | 8,330,000 | 60,559,000 | 2.39% | ||
| 16 | JUNO THERAPEUTICS INCORPORATED | 1,305,000 | 50,164,000 | 1.98% | ||
| 17 | ALDER BIOPHARMACEUTICALS INC | 1,685,150 | 42,078,000 | 1.66% | ||
| 18 | KITE PHARMA INCORPORATED | 750,000 | 37,500,000 | 1.48% | ||
| 19 | INTERCEPT PHARMACEUTICAL | 255,719 | 36,486,000 | 1.44% | ||
| 20 | CEMPRA INC | 2,041,900 | 33,671,000 | 1.33% | ||
| 21 | INTRA CELLULAR THERAPIES INC COM | 700,000 | 27,174,000 | 1.07% | ||
| 22 | SAGE THERAPEUTICS | 850,639 | 25,630,000 | 1.01% | ||
| 23 | MACROGENICS INC | 520,000 | 14,035,000 | 0.55% | ||
| 24 | PUMA BIOTECHNOLOGY | 431,991 | 12,869,000 | 0.51% | ||
| 25 | PROTHENA CORP PLC | 350,000 | 12,236,000 | 0.48% | ||
| 26 | ACHILLION PHARMACEUTICALS INC COM | 1,279,340 | 9,979,000 | 0.39% | ||
| 27 | Esperion Therapeutics Inc | 1,008,542 | 9,964,000 | 0.39% | ||
| 28 | PTC THERAPEUTICS INC | 1,182,912 | 8,304,000 | 0.33% | ||
| 29 | CIDARA THERAPEUTICS INC | 746,824 | 7,700,000 | 0.30% | ||
| 30 | TOBIRA THERAPEUTICS INC | 468,000 | 5,878,000 | 0.23% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-019821, filed 2016.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
